Stock Analysis on Net

AmerisourceBergen Corp. (NYSE:ABC)

$22.49

This company has been moved to the archive! The financial data has not been updated since August 2, 2023.

Analysis of Solvency Ratios
Quarterly Data

Microsoft Excel

Paying user area

The data is hidden behind: . Unhide it.

This is a one-time payment. There is no automatic renewal.


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Solvency Ratios (Summary)

AmerisourceBergen Corp., solvency ratios (quarterly data)

Microsoft Excel
Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017
Debt Ratios
Debt to equity
Debt to capital
Debt to assets
Financial leverage

Based on: 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-Q (reporting date: 2022-12-31), 10-K (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-Q (reporting date: 2021-12-31), 10-K (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-Q (reporting date: 2020-12-31), 10-K (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-Q (reporting date: 2019-12-31), 10-K (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-Q (reporting date: 2018-12-31), 10-K (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31), 10-Q (reporting date: 2017-12-31).


The analysis of the financial leverage ratios over the observed periods indicates a generally stable leverage position with some marked anomalies in certain quarters.

Debt to Equity Ratio
The debt to equity ratio remained relatively stable from December 2017 through June 2020, fluctuating mildly between approximately 1.4 and 1.5. Notably, it exhibited a declining trend during early 2020, reaching a low of 1.07 in June 2020. However, from September 2020 onwards, this ratio experienced extreme volatility with an unusual spike to 187.1 in September 2020, followed by a decrease but still elevated figures peaking at 29.93 in December 2020, and then moving towards normalization, albeit still high relative to previous years. The latest quarters show a much reduced ratio around 7.32 in June 2023, which is still significantly above the pre-2020 levels.
Debt to Capital Ratio
The debt to capital ratio held steady around 0.59 to 0.6 from December 2017 to September 2019. A downward trend was observed in early 2020, dropping to a minimum of 0.52 in June 2020. Following that, an abrupt increase occurred reaching 1.33 by September 2020. Subsequently, the ratio displayed fluctuations but predominantly maintained values close to or just above 1.0 through the most recent quarters, suggesting a structural shift in the proportion of debt relative to the company's capital base as compared to earlier periods.
Debt to Assets Ratio
This ratio remained relatively low and stable throughout the entire period, consistently ranging between 0.08 and 0.13. There was a slight decrease around mid-2020, coinciding with overall declines in other leverage metrics during the same timeframe. The steadiness of this ratio suggests limited variation in the company's reliance on debt to finance its assets over time despite fluctuations in other leverage aspects.
Financial Leverage Ratio
Financial leverage exhibited stability from December 2017 to June 2020, ranging between approximately 10.57 and 13.61. From September 2020 forward, this ratio encountered extreme spikes with an extraordinary surge to 1473.34 in September 2020 and further variability at elevated levels in subsequent quarters (e.g., 256.71 in December 2020). The values eventually decreased but remained substantially higher than the pre-2020 range, reflecting large changes in the company’s asset-to-equity funding structure in recent years.

Overall, the company displayed stable leverage metrics prior to 2020, with ratios indicating moderate reliance on debt financing. Starting in mid to late 2020, there were significant volatility and pronounced spikes in debt-related ratios, suggesting possible accounting restatements, restructuring events, or extraordinary financial activities affecting capital structure. Despite the high fluctuations in debt to equity and financial leverage, the debt to assets ratio remained comparatively consistent, implying a more stable asset base relative to debt exposure. Recent quarters show a partial reversion toward more normalized leverage levels, though still elevated compared to the pre-2020 period.


Debt Ratios


Debt to Equity

AmerisourceBergen Corp., debt to equity calculation (quarterly data)

Microsoft Excel
Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017
Selected Financial Data (US$ in thousands)
Short-term debt
Long-term debt, net of current portion
Total debt
 
Total AmerisourceBergen Corporation stockholders’ equity (deficit)
Solvency Ratio
Debt to equity1
Benchmarks
Debt to Equity, Competitors2
Abbott Laboratories
Elevance Health Inc.
Intuitive Surgical Inc.
Medtronic PLC
UnitedHealth Group Inc.

Based on: 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-Q (reporting date: 2022-12-31), 10-K (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-Q (reporting date: 2021-12-31), 10-K (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-Q (reporting date: 2020-12-31), 10-K (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-Q (reporting date: 2019-12-31), 10-K (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-Q (reporting date: 2018-12-31), 10-K (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31), 10-Q (reporting date: 2017-12-31).

1 Q3 2023 Calculation
Debt to equity = Total debt ÷ Total AmerisourceBergen Corporation stockholders’ equity (deficit)
= ÷ =

2 Click competitor name to see calculations.


Total Debt
Total debt demonstrated fluctuations over the observed periods. Starting at approximately $4.29 billion at the end of 2017, it remained relatively stable with minor decreases and increases through 2019. A notable reduction occurred at the end of 2020, falling to about $3.7 billion. However, there was a significant upward spike during the first three quarters of 2021, peaking around $7.1 billion. Following this peak, total debt gradually decreased through 2022 and into mid-2023, reaching approximately $5.0 billion by June 2023.
Stockholders' Equity
Stockholders’ equity exhibited considerable volatility. From a base near $2.87 billion at the end of 2017, it trended generally upward through the early part of 2020, peaking around $3.86 billion in March 2020. Subsequently, there was a dramatic decline, turning negative by September 2020 with a deficit exceeding $1 billion. This negative equity persisted with variability through 2021, briefly returning to positive territory toward the end of that year. From early 2022 onward, equity displayed fluctuations between positive and negative values, ultimately rising to about $686 million by mid-2023.
Debt to Equity Ratio
The debt to equity ratio initially remained in a relatively narrow band around 1.4 to 1.5 through late 2019, suggesting a moderate leverage position. This ratio decreased notably through early 2020, reaching near 1.07, consistent with a temporary reduction in leverage. Starting in late 2020 and throughout 2021, the ratio exhibited extreme volatility, with exceptionally high values recorded during this period, including values above 180 and around 30, indicating significant financial instability likely related to the negative equity observed. In 2022 and 2023, while the ratio decreased substantially from these extreme peaks, it remained elevated relative to earlier periods, fluctuating between approximately 7 and 17, signaling a still high but improving leverage situation.
Summary
The financial data reflects a period of relative stability in leverage and equity through 2019, followed by a sharp deterioration in equity and a corresponding spike in leverage metrics through 2020 and 2021. This could suggest significant financial restructuring or one-time events impacting the balance sheet during this time. Although there has been a gradual recovery in both equity and debt levels from 2022 onward, capital structure remains more leveraged compared to earlier periods. Overall, these trends indicate a phase of financial stress and recovery with implications for risk and solvency assessment.

Debt to Capital

AmerisourceBergen Corp., debt to capital calculation (quarterly data)

Microsoft Excel
Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017
Selected Financial Data (US$ in thousands)
Short-term debt
Long-term debt, net of current portion
Total debt
Total AmerisourceBergen Corporation stockholders’ equity (deficit)
Total capital
Solvency Ratio
Debt to capital1
Benchmarks
Debt to Capital, Competitors2
Abbott Laboratories
Elevance Health Inc.
Intuitive Surgical Inc.
Medtronic PLC
UnitedHealth Group Inc.

Based on: 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-Q (reporting date: 2022-12-31), 10-K (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-Q (reporting date: 2021-12-31), 10-K (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-Q (reporting date: 2020-12-31), 10-K (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-Q (reporting date: 2019-12-31), 10-K (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-Q (reporting date: 2018-12-31), 10-K (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31), 10-Q (reporting date: 2017-12-31).

1 Q3 2023 Calculation
Debt to capital = Total debt ÷ Total capital
= ÷ =

2 Click competitor name to see calculations.


Total Debt Trend
The total debt generally exhibited moderate fluctuations between the end of 2017 and the end of 2020, maintaining a level around 4.1 to 4.5 billion US dollars. A notable decrease occurred by the end of 2020, dropping to approximately 3.7 billion US dollars. However, a substantial increase followed in early 2021, peaking above 7 billion US dollars in mid-2021. Subsequently, total debt declined steadily through 2022 and the first half of 2023, reaching just over 5 billion US dollars by June 2023.
Total Capital Trend
Total capital demonstrated relative stability from late 2017 through early 2020, mostly ranging between approximately 7.1 billion and 8 billion US dollars. A sharp contraction occurred by September 2020, dipping below 3.1 billion US dollars, followed by a recovery phase beginning in early 2021. Total capital increased notably to above 7 billion US dollars in mid-2021 and then displayed a gradual downward trend thereafter, ending at about 5.7 billion US dollars in June 2023.
Debt to Capital Ratio Analysis
The debt to capital ratio remained relatively stable at around 0.58 to 0.60 from late 2017 to early 2020, indicating a consistent balance between debt and capital. A significant anomaly occurred in late 2020, with the ratio spiking to 1.33, reflecting a disproportionate increase in debt relative to total capital. This elevated ratio gradually declined through 2021 and early 2022, settling near 0.88 by mid-2023. Ratios above 1 during late 2020 and parts of 2021 signify that total debt exceeded total capital at those points, indicating high leverage during that period.
Overall Insights
The data reveals a period of heightened financial leverage around late 2020 and early 2021, marked by a sharp rise in debt and a concurrent drop in capital, significantly increasing the debt to capital ratio above 1. This phase was followed by gradual deleveraging and partial recovery of capital. The trend towards decreasing total capital and debt after the peak suggests efforts to restore financial balance. The fluctuations in leverage could be reflective of strategic financial decisions in response to external or internal factors affecting the company during the analyzed periods.

Debt to Assets

AmerisourceBergen Corp., debt to assets calculation (quarterly data)

Microsoft Excel
Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017
Selected Financial Data (US$ in thousands)
Short-term debt
Long-term debt, net of current portion
Total debt
 
Total assets
Solvency Ratio
Debt to assets1
Benchmarks
Debt to Assets, Competitors2
Abbott Laboratories
Elevance Health Inc.
Intuitive Surgical Inc.
Medtronic PLC
UnitedHealth Group Inc.

Based on: 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-Q (reporting date: 2022-12-31), 10-K (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-Q (reporting date: 2021-12-31), 10-K (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-Q (reporting date: 2020-12-31), 10-K (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-Q (reporting date: 2019-12-31), 10-K (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-Q (reporting date: 2018-12-31), 10-K (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31), 10-Q (reporting date: 2017-12-31).

1 Q3 2023 Calculation
Debt to assets = Total debt ÷ Total assets
= ÷ =

2 Click competitor name to see calculations.


Total Debt
The total debt exhibited modest fluctuations over the observed periods, starting at approximately $4.29 billion at the end of 2017, and showing a slight decline by late 2020 to around $3.7 billion. However, a notable increase occurred in early 2021, with debt surging to over $7 billion by mid-2021. Subsequently, total debt decreased gradually throughout late 2021 to mid-2023, ending at approximately $5 billion. This pattern indicates a significant borrowing event in early 2021 followed by debt reduction efforts.
Total Assets
Total assets demonstrated an overall upward trend across the entire timeframe. Assets grew steadily from roughly $36.4 billion at the end of 2017 to nearly $44.3 billion by late 2020. A pronounced acceleration in asset growth occurred during 2021, with assets surpassing $55.9 billion by mid-year and continuing to increase, reaching about $61.2 billion by mid-2023. This consistent growth suggests expansion activities, possibly through acquisitions or organic growth.
Debt to Assets Ratio
The debt to assets ratio remained relatively stable and low for much of the period, fluctuating between 0.09 and 0.13. Initially hovering around 0.11 to 0.12, the ratio decreased slightly through 2020 to a low of 0.08. A sharp rise was observed in early 2021, aligning with the spike in total debt, raising the ratio to approximately 0.13. Following this peak, there was a gradual decline in the ratio during subsequent quarters, returning to a level near 0.08 by mid-2023. This indicates the company's ability to manage its leverage effectively despite fluctuations in borrowing levels.

Financial Leverage

AmerisourceBergen Corp., financial leverage calculation (quarterly data)

Microsoft Excel
Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017
Selected Financial Data (US$ in thousands)
Total assets
Total AmerisourceBergen Corporation stockholders’ equity (deficit)
Solvency Ratio
Financial leverage1
Benchmarks
Financial Leverage, Competitors2
Abbott Laboratories
Elevance Health Inc.
Intuitive Surgical Inc.
Medtronic PLC
UnitedHealth Group Inc.

Based on: 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-Q (reporting date: 2022-12-31), 10-K (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-Q (reporting date: 2021-12-31), 10-K (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-Q (reporting date: 2020-12-31), 10-K (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-Q (reporting date: 2019-12-31), 10-K (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-Q (reporting date: 2018-12-31), 10-K (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31), 10-Q (reporting date: 2017-12-31).

1 Q3 2023 Calculation
Financial leverage = Total assets ÷ Total AmerisourceBergen Corporation stockholders’ equity (deficit)
= ÷ =

2 Click competitor name to see calculations.


Total Assets
The total assets demonstrate a general upward trend over the time period analyzed. Starting from approximately $36.36 billion at the end of 2017, total assets increased to around $61.18 billion by mid-2023. There are some fluctuations in the quarterly figures; however, the overall pattern reflects consistent growth. Notably, there was a significant increase in total assets commencing in early 2021, which continued through 2023, indicating expansion or asset acquisition during this period.
Stockholders’ Equity
The stockholders’ equity shows more variability across quarters. Initially, it increased moderately from about $2.87 billion at the end of 2017 to approximately $3.86 billion by the end of the first quarter in 2020. Following this, a sharp and unusual decline occurred starting in the third quarter of 2020, leading to negative equity figures until near the end of 2021. Post this period, a recovery trend is visible, with equity returning to positive territory and reaching approximately $686 million by mid-2023. This volatility and temporary negative equity suggest periods of financial strain or significant accounting adjustments that impacted the net asset value available to shareholders.
Financial Leverage
Financial leverage ratios were relatively stable and low, ranging between about 10.57 and 13.61 through the first quarter of 2020, indicating moderate use of debt relative to equity during this period. However, starting in the third quarter of 2020, the leverage ratio shows extreme volatility with very high values recorded at multiple points, such as 1473.34, 256.71, and other sizable figures extending into 2022 and beyond. The episodes of extremely high leverage coincide with periods of negative or near-zero equity, magnifying the leverage metric dramatically. This suggests that the company faced significant leverage risk during this time, likely due to the substantial decline in equity. The most recent quarters show a decrease in leverage from its peak but still remain elevated compared to the pre-2020 period.
Summary and Insights
The data reveals an overall growth in asset size, which could reflect business expansion or increased investments. However, the disparity between asset growth and stockholders’ equity during 2020 and 2021 points to financial challenges, such as potential losses or large liabilities that eroded equity. The unusually high financial leverage ratios in the same period further emphasize heightened financial risk due to a weakened equity base. The subsequent rebound in equity and reduction of leverage ratios suggest a recovery phase, but the leverage remains higher than historically observed, which could imply ongoing reliance on debt or residual financial risk. Continuous monitoring of equity and leverage measures would be prudent to assess the sustainability of the company’s capital structure moving forward.